Web Results

Subsidiaries of the Company - SEC.gov

www.sec.gov/Archives/edgar/data/78003/000119312512085703/d278590dex21.htm

PF Asia Manufacturing Coöperatief U.A.. Netherlands. PF PR Holdings C.V.. Netherlands. PF PRISM C.V.. Netherlands. PF PRISM Holdings S.a.r.l.. Luxembourg.

Pfizer, Wyeth and PF Prism file suit against Watson over generic Pristiq

www.news-medical.net/news/20120626/Pfizer-Wyeth-and-PF-Prism-file-suit-against-Watson-over-generic-Pristiq.aspx

Jun 26, 2012 ... Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V. filed suit against Watson on June 22, 2012 in the United States District ...

Pf prism cv drug patent status and generic equivalents

www.drugpatentwatch.com/ultimate/applicant/Pf Prism Cv

Pf prism cv drug patent expiration information and generic drug list.

N021446 - Orange Book: Approved Drug Products with Therapeutic ...

www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=021446&TABLE1=OB_Rx

Applicant: PF PRISM CV. Strength: 25MG. Application Number: N021446. Product Number: 001. Approval Date: Dec 30, 2004. Reference Listed Drug, No.

Xeljanz - U.S. Food and Drug Administration

www.accessdata.fda.gov/drugsatfda_docs/rems/Xeljanz_2015.06.19_REMS_full.pdf

REMS. Initial REMS Approval: 11/06/2012. Most Recent Modification: 6/2015. NDA 203,214 XELJANZ. ®. (TOFACITINIB). PF PRISM C.V. c/o Pfizer Netherlands, ...

Application Form - EPA

www.epa.ie/licences/lic_eDMS/090151b280403d23.pdf

Oct 28, 2011 ... PF PRISM C.V. is 100% owned by CP Pharmaceuticals ... C.P. Pharmaceuticals International C.V. is a limited partnership (commanditaire.

in the united states district court for the district of delaware pfizer inc ...

delawareintellectualproperty.wp.lexblogs.com/wp-content/uploads/sites/21/2014/11/Pfizer-Opinion-Oct-22-2014.pdf

Pharmaceuticals LLC, and PF Prism C.V. (collectively, "Pfizer") allege that ... Plaintiff C.P. Pharmaceuticals International C.V. ("CPPI CV") is a limited partnership.

Generic Rapamune Availability - Drugs.com

www.drugs.com/availability/generic-rapamune.html

RAPAMUNE (sirolimus - solution;oral). Manufacturer: PF PRISM CV Approval date: September 15, 1999. Strength(s): 1MG/ML ...

Generic Vfend Availability - Drugs.com

www.drugs.com/availability/generic-vfend.html

VFEND (voriconazole - for suspension;oral). Manufacturer: PF PRISM CV Approval date: December 19, 2003. Strength(s): 200MG/5ML ...

Generic Lyrica Availability - Drugs.com

www.drugs.com/availability/generic-lyrica.html

LYRICA (pregabalin - capsule;oral). Manufacturer: PF PRISM CV Approval date: December 30, 2004. Strength(s): 25MG, 50MG, 75MG, 100MG, 150MG, 200MG,  ...

More Info

PF PRISM CV - FDA Drug License Applications | FDAzilla

fdazilla.com

PF PRISM CV is a drugmaker with 12 approved drug applications: 12 New Drug Application(s), 0 Biologics License Application(s), and 0 Abbreviated New Drug ...

PF Prism C V - DNA

www.dnaindia.com

Jan 27, 2016 ... PF Prism C V News - Check out the latest News on PF Prism C V. Get breaking news updates on PF Prism C V and published at Daily News ...

View Complaint - RPX Search

search.rpxcorp.com

Sep 27, 2013 ... PHARMACEUTICALS LLC, PF PRISM C.V., and. PFIZER MANUFACTURING ... Plaintiff PF PRISM C.V. is a limited partnership (commanditaire.